Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG/Rij rat model of absence epilepsy
- PMID: 25754610
- PMCID: PMC4459032
- DOI: 10.1111/bph.13121
Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG/Rij rat model of absence epilepsy
Abstract
Background and purpose: Two of the most relevant unmet needs in epilepsy are represented by the development of disease-modifying drugs able to affect epileptogenesis and/or the study of related neuropsychiatric comorbidities. No systematic study has investigated the effects of chronic treatment with antipsychotics or antidepressants on epileptogenesis. However, such drugs are known to influence seizure threshold.
Experimental approach: We evaluated the effects of an early long-term treatment (ELTT; 17 weeks), started before seizure onset (P45), with fluoxetine (selective 5-HT-reuptake inhibitor), duloxetine (dual-acting 5-HT-noradrenaline reuptake inhibitor), haloperidol (typical antipsychotic drug), risperidone and quetiapine (atypical antipsychotic drugs) on the development of absence seizures and comorbid depressive-like behaviour in the WAG/Rij rat model. Furthermore, we studied the effects of these drugs on established absence seizures in adult (6-month-old) rats after a chronic 7 weeks treatment.
Key results: ELTT with all antipsychotics did not affect the development of seizures, whereas, both ELTT haloperidol (1 mg · kg(-1) day(-1)) and risperidone (0.5 mg · kg(-1) day(-1)) increased immobility time in the forced swimming test and increased absence seizures only in adult rats (7 weeks treatment). In contrast, both fluoxetine (30 mg · kg(-1) day(-1)) and duloxetine (10-30 mg · kg(-1) day(-1)) exhibited clear antiepileptogenic effects. Duloxetine decreased and fluoxetine increased absence seizures in adult rats. Duloxetine did not affect immobility time; fluoxetine 30 mg · kg(-1) day(-1) reduced immobility time while at 10 mg · kg(-1) day(-1) an increase was observed.
Conclusions and implications: In this animal model, antipsychotics had no antiepileptogenic effects and might worsen depressive-like comorbidity, while antidepressants have potential antiepileptogenic effects even though they have limited effects on comorbid depressive-like behaviour.
© 2015 The British Pharmacological Society.
Figures


Similar articles
-
Antiepileptogenic effects of Ethosuximide and Levetiracetam in WAG/Rij rats are only temporary.Pharmacol Rep. 2019 Oct;71(5):833-838. doi: 10.1016/j.pharep.2019.04.017. Epub 2019 Apr 24. Pharmacol Rep. 2019. PMID: 31386986
-
mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy.Neuropharmacology. 2013 Jun;69:25-36. doi: 10.1016/j.neuropharm.2012.09.019. Epub 2012 Oct 22. Neuropharmacology. 2013. PMID: 23092918
-
Protective effects of some statins on epileptogenesis and depressive-like behavior in WAG/Rij rats, a genetic animal model of absence epilepsy.Epilepsia. 2014 Aug;55(8):1284-91. doi: 10.1111/epi.12686. Epub 2014 Jun 24. Epilepsia. 2014. PMID: 24962151
-
The WAG/Rij strain: a genetic animal model of absence epilepsy with comorbidity of depression [corrected].Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 1;35(4):854-76. doi: 10.1016/j.pnpbp.2010.11.010. Epub 2010 Nov 17. Prog Neuropsychopharmacol Biol Psychiatry. 2011. PMID: 21093520 Review.
-
Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity.Neuropharmacology. 2013 Jan;64:371-9. doi: 10.1016/j.neuropharm.2012.06.039. Epub 2012 Jul 2. Neuropharmacology. 2013. PMID: 22766393 Review.
Cited by
-
Absence seizures and their relationship to depression and anxiety: Evidence for bidirectionality.Epilepsia. 2021 May;62(5):1041-1056. doi: 10.1111/epi.16862. Epub 2021 Mar 10. Epilepsia. 2021. PMID: 33751566 Free PMC article.
-
N-acetylcysteine aggravates seizures while improving depressive-like and cognitive impairment comorbidities in the WAG/Rij rat model of absence epilepsy.Mol Neurobiol. 2022 May;59(5):2702-2714. doi: 10.1007/s12035-021-02720-3. Epub 2022 Feb 15. Mol Neurobiol. 2022. PMID: 35167014
-
Antidepressant Drugs for Seizures and Epilepsy: Where do we Stand?Curr Neuropharmacol. 2023;21(8):1691-1713. doi: 10.2174/1570159X20666220627160048. Curr Neuropharmacol. 2023. PMID: 35761500 Free PMC article. Review.
-
Optimization of Therapy in Patients with Epilepsy and Psychiatric Comorbidities: Key Points.Curr Neuropharmacol. 2023;21(8):1755-1766. doi: 10.2174/1570159X20666220526144314. Curr Neuropharmacol. 2023. PMID: 35619263 Free PMC article.
-
Sigma-1 receptor and seizures.Pharmacol Res. 2023 May;191:106771. doi: 10.1016/j.phrs.2023.106771. Epub 2023 Apr 15. Pharmacol Res. 2023. PMID: 37068533 Free PMC article. Review.
References
-
- Ahern TH, Javors MA, Eagles DA, Martillotti J, Mitchell HA, Liles LC, et al. The effects of chronic norepinephrine transporter inactivation on seizure susceptibility in mice. Neuropsychopharmacology. 2006;31:730–738. - PubMed
-
- Bagdy G, Kecskemeti V, Riba P, Jakus R. Serotonin and epilepsy. J Neurochem. 2007;100:857–873. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical